Otoimmün Poliglandüler Sendromlar Hastalık Tanımı ve Fizyopatolojik Temeller
Özet
Referanslar
Kahaly GJ, et al. Nat Rev Endocrinol. 2021;17(7):412-424. APS-2 Fizyopatolojisi Kahaly, G. J. (2009). "Polyglandular autoimmune syndromes." European Journal of Endocrinology, 161(1), 11-20. Kahaly, G. J., et al. (2019). "Polyglandular autoimmune syndromes: Immunogenetics and long-term follow-up." Journal of Clinical Endocrinology & Metabolism, 104(11), 5225-5233.
Husebye ES, et al. J Intern Med. 2018;283(6):558-572. Husebye, E. S., et al. (2018). "Autoimmune polyendocrine syndromes." Nature Reviews Disease Primers, 4(1), 1-18
Michels AW, Eisenbarth GS. Annu Rev Immunol. 2011;29:447-485. Michels, A. W., & Gottlieb, P. A. (2010). "Autoimmune polyglandular syndromes." Nature Reviews Endocrinology, 6(5), 270-277. Eisenbarth, G. S., & Gottlieb, P. A. (2004). "Autoimmune polyendocrine syndromes." New England Journal of Medicine, 350(20), 2068-2079.
Frommer L, et al. Front Immunol. 2020;11:628. Frommer L, et al. Eur J Endocrinol. 2018;178(5):543-552.
Betterle C, et al. J Clin Endocrinol Metab. 2019;104(2):476-490. Betterle C, et al. J Clin Endocrinol Metab. 2002;87(3):997-1003.Betterle C et al. Autoimmune Polyendocrine Syndromes: Genetic Background and Clinical Features. Front Horm Res, 2019
American Diabetes Association. Diabetes Care. 2023;46(Suppl 1):S140-S157.
Bornstein SR, et al. Lancet. 2016;387(10021):913-924.
Peterson, P., et al. (2008). "Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): A model disease to study molecular aspects of endocrine autoimmunity." Clinical and Experimental Immunology, 135(3), 348-357.
Laakso SM, et al. Regulatory T Cell Deficiency in APECED Is a Functionally Defined Abnormality That Can Be Corrected by IL-2. J Immunol. 2019;203(11):3018-3026. doi: 10.4049/jimmunol.1900432.
Nagamine K, et al. Genomics. 1997;42(1):141-146.
Bottomley MJ, et al. J Biol Chem. 2001;276(44):41357-41364.
Liston A, et al. Immunity. 2003;19(6):903-912.
Finnish-German APECED Consortium. Nat Genet. 1997;17(4):393-398.
Heino M, et al. Hum Mutat. 2000;15(3):293-294.
Orlova EM, et al. Clin Genet. 2010;77(4):370-380 Orlova, E. M., et al. (2020). "Autoimmune polyglandular syndrome type 1: A focus on immune dysregulation." Clinical Immunology, 214, 108385.
Myhre AG, et al. J Clin Endocrinol Metab. 2002;87(3):997-1003.
Ward L, et al. J Pediatr. 1999;134(6):782-784.
Kekäläinen E, et al. J Immunol. 2007;178(10):6031-6037.(2007). *"T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009. H1N1influenza A epitope in narcolepsy."*Nature Immunology, 8(12), 1284–1291. DOI: 10.1038/ni1522
Kisand K, et al. J Exp Med. 2010;207(13):2995-3006. Kisand, K., & Peterson, P. (2020). "Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): A comprehensive review." Journal of Autoimmunity, 110,102443.
Meloni A, et al. J Autoimmun. 2008;31(2):142-148.
PuelA,et al. Science. 2011;332(6025):65-68. Puel A, et al. Science. 2010;332(6025):65-68.
Vojdani A. Front Immunol. 2014;5:166.
Ruiz PJ, et al. J Immunol. 2000;164(6):2990-2995.
Cetani F, et al. Eur J Endocrinol. 2001;144(4):377-381.
Pappas PG, et al. Clin Infect Dis. 2016;62(4):e1-e50.
Lionakis MS, et al. N Engl J Med. 2014;370(18):1760-1771.
Bollerslev J, et al. Eur J Endocrinol. 2015;173(2):G1-G20.
Le V, et al. J Allergy Clin Immunol. 2019;143(6):2278-2281.
Rosenzwajg M, et al. Sci Transl Med. 2019;11(489):eaaw5510.
Tenti S, et al. Autoimmun Rev. 2019;18(5):477-490.
Perheentupa J. J Clin Endocrinol Metab. 2006;91(8):2843-2850.
Rushworth RL, et al. Clin Endocrinol. 2019;90(1):15-22.
Marx A, et al. Nat Rev Cancer. 2015;15(7):424-434.
Rautemaa R, et al. Oral Dis. 2007;13(2):196-205.
Kawasaki E, et al. J Clin Endocrinol Metab. 2016;101(4):1381-1389.
Wenzlau JM, et al. Diabetes. 2007;56(12):3020-3028.
Ueda H, et al. Nature. 2003;423(6939):506-511.
Bottini N, Peterson EJ. Curr Opin Immunol. 2014;31:73-78.
Ziegler AG, et al. Diabetes Care. 2013;36(9):2616-2620.
McLachlan SM, Rapoport B. Endocr Rev. 2014;35(1):59-105.
Long SA, Buckner JH. J Immunol. 2011;186(8):4649-4655.
Gagliani N, et al. Immunity. 2015;43(2):251-263.
Bratland E, et al. J Immunol. 2011;186(2):1209-1216.
Figueroa-Vega N, et al. J Immunol. 2010;184(2):929-935.
Korn T, et al. Annu Rev Immunol. 2009;27:485-517.
Smith TJ, Hegedüs L. Lancet. 2016;388(10047):906-918.
Holt RIG, et al. Diabet Med. 2021;38(5):e14515.
Caio G, et al. Nutrients. 2019;11(10):2375.
Toh BH, et al. Autoimmun Rev. 2017;16(1):75-82.
Bergqvist C, Ezzedine K. Am J Clin Dermatol. 2019;20(1):1-12.
Ospina NS, et al. J Clin Endocrinol Metab. 2016;101(2):364-389.
Jonklaas J, et al. Thyroid. 2014;24(12):1670-1751.
American Diabetes Association. Diabetes Care. 2021;44(Suppl 1):S53-S72.
Miyara M, et al. Immunol Rev. 2011;241(1):132-159.
Erichsen MM, et al. Eur J Endocrinol. 2009;160(2):233-237.
Hoang JK, et al. Radiology. 2013;267(3):672-682.
Ross DS, et al. Thyroid. 2016;26(10):1343-1421.
Orban T, et al. Diabetes Care. 2014;37(4):1069-1075.
Herold KC, et al. N Engl J Med. 2019;381(7):603-613.
Laureti S, et al. J Clin Endocrinol Metab. 1996;81(12):4707-4711.
Fiore E, et al. Thyroid. 2009;19(12):1403-1410.
İmmünolojik Mekanizmalar Laakso, S. M., et al. (2019). "Regulatory T cell defects in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients." Journal of Autoimmunity, 103, 102288.
Anderson, M. S., & Su, M. A. (2016). "AIRE expands: new roles in immune tolerance and beyond." Nature Reviews Immunology, 16(4), 247-258. AIRE geninin immün toleranstaki rolünü ve APS-1 ile ilişkisini açıklayan bir makale.
Bruserud, ., et al. (2018). "AIRE mutations and autoimmune diseases: A systematic review." Journal of Allergy and Clinical Immunology, 141(5), 1594-1603.)
Jerne, N. K. (1974). "Towards a network theory of the immune system." Annals of Immunology, 125C(1-2), 373-389.
Wincent, A., et al. (1999). "Anti-idiotypic antibodies in autoimmune diseases." Immunology Today, 20(5), 234-240.Antiidiotip antikorların otoimmün hastalıklardaki rolünü inceleyen bir çalışma..
Sakaguchi, S. et al. (2008). Cell. (Treg hücrelerinin immün toleranstaki rolü).
Mauri, C. & Bosma, A. (2012). Nat Rev Immunol. (Breg hücreleri ve anti-idiyotipik antikorlar).
Tzioufas et al., 2012 (IVIG'in otoimmün hastalıklardaki rolü)
Smith et al., 2020 (Otoimmün endokrinopatilerde biyolojik tedaviler)
Hober D, Sauter P. Viruses and Autoimmunity. 2010.
Oftedal BE, et al. J Clin Endocrinol Metab. 2015;100(1):E1-E8.
Jeffery LE, et al. J Immunol. 2012;188(5):2127-2135.
Zheng Y, et al. Nat Commun. 2020;11(1):2575.
Gavalas NG, et al. J Clin Endocrinol Metab. 2007;92(6):2105-2110.
Mitchell AL, et al. Diabetes. 2019;68(3):652-662.
Arif S, et al. Diabetologia. 2011;54(7):1778-1789.
Emamaullee JA, et al. Diabetes. 2009;58(1):100-109.
Li D, et al. Cell Death Dis. 2014;5:e1489.
Wang B, et al. J Immunol. 2012;188(1):370-379.
Stylianou C, et al. Cell Death Differ. 2015;22(9):1445-1456.
Pauley KM, et al. J Immunol. 2011;186(4):2392-2401.
Ferré EM, et al. J Clin Invest. 2016;126(4):1513-1528.
Saeki H, et al. J Dermatol. 2019;46(6):476-481.
Toussirot É, et al. Autoimmun Rev. 2020;19(3):102490.
Choi J, et al. Diabetes. 2019;68(4):706-718.
Cutolo M, et al. Autoimmun Rev. 2022;21(3):103013.
Tsokos GC. N Engl J Med. 2011;365(22):2110-2121.
Gilhus NE, et al. Lancet Neurol. 2016;15(10):1023-1036.
Moutsopoulos HM. Lancet. 2014;383(9919):321-332.
Aringer M, et al. Ann Rheum Dis. 2019;78(6):736-745.
Meriggioli MN, Sanders DB. Lancet Neurol. 2009;8(5):475-490. Sanders DB, et al. Neurology. 2016;87(4):419-425.
Bernatsky S, et al. Ann Rheum Dis. 2016;75(4):689-693.
Smolen JS, et al. Lancet. 2016;388(10055):2023-2038.
Lohse AW, et al. J Hepatol. 2015;62(1):S100-S111.
Antonelli A, et al. Endocr Rev. 2020;41(6):891-904.
Eizirik DL, et al. Nat Rev Endocrinol. 2020;16(6):349-362.
Morris DL, et al. Nat Genet. 2016;48(5):510-518.
Gregersen PK, et al. Nat Immunol. 2020;21(7):695-699.
Kariuki SN, Niewold TB. Curr Opin Rheumatol. 2011;23(5):444-448.
Vincent FB, et al. Autoimmun Rev. 2014;13(3):272-279.
Spolski R, Leonard WJ. Nat Rev Immunol. 2014;14(3):154-165.
Ronnblom L, Eloranta ML. Annu Rev Immunol. 2013;31:387-415.
Pender MP, Burrows SR. Nat Rev Neurol. 2014;10(1):15-23.
ACR. Arthritis Care Res. 2019;71(6):717-734.
Kimura A, Kishimoto T. Immunity. 2010;32(4):504-513.
Fanouriakis A, et al. Ann Rheum Dis. 2019;78(6):736-745.
Furie R, et al. Arthritis Rheumatol. 2020;72(2):232-243.
Tandan R, et al. Muscle Nerve. 2017;56(1):148-156.
O'Shea JJ, et al. Annu Rev Med. 2015;66:311-328.
Tektonidou MG, et al. J Am Soc Nephrol. 2017;28(8):2521-2529.
Varga, E., & Farid, N. R. (2009). "The idiotypic network and endocrine autoimmunity: A theoretical framework for Graves' disease and Hashimoto Thyroiditis." Autoimmunity Reviews, *8*(7),592596. https://doi.org/10.1016/j.autrev.2009.02.013 DOI: 10.1016/j.autrev.2009.02.013
Pugliese, A., Yang, M., Kusmarteva, I., Heiple, T., Vendrame, F., Wasserfall, C., & Atkinson, M. A. (2018). "The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: Goals, Operational Model, and Emerging Findings."
Joshi et al. "T cells in patients with narcolepsy target self-antigens of hypocretin neurons" :Nature 2011: 479(7372), s. 216-219 DOI: 10.1038/nature10554
Polanczyk et al "Cutting Edge: Estrogen Drives Expansion of the CD4+CD25+ Regulatory T Cell Compartment" The Journal of Immunology 2004: 173(4),s.2227-2230PMID: 15294932 DOI: 10.4049/jimmunol.173.4.2227
Cocco et,all."Retinal ganglion cell loss in autoimmune optic neuritis: Insights from an experimental model" Journal of Neuroinflammation 2020 17(1), s. 156 PMID: 32 "
Aringer M, Costenbader K, Daikh D, et al. "2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for systemic lupus eritematozus Annals of theRheumatoidDiseases’’2019;78(6):736-745.PMID: 31383717. DOI: 10.1136/annrheumdis-2018-214819
Referanslar
Kahaly GJ, et al. Nat Rev Endocrinol. 2021;17(7):412-424. APS-2 Fizyopatolojisi Kahaly, G. J. (2009). "Polyglandular autoimmune syndromes." European Journal of Endocrinology, 161(1), 11-20. Kahaly, G. J., et al. (2019). "Polyglandular autoimmune syndromes: Immunogenetics and long-term follow-up." Journal of Clinical Endocrinology & Metabolism, 104(11), 5225-5233.
Husebye ES, et al. J Intern Med. 2018;283(6):558-572. Husebye, E. S., et al. (2018). "Autoimmune polyendocrine syndromes." Nature Reviews Disease Primers, 4(1), 1-18
Michels AW, Eisenbarth GS. Annu Rev Immunol. 2011;29:447-485. Michels, A. W., & Gottlieb, P. A. (2010). "Autoimmune polyglandular syndromes." Nature Reviews Endocrinology, 6(5), 270-277. Eisenbarth, G. S., & Gottlieb, P. A. (2004). "Autoimmune polyendocrine syndromes." New England Journal of Medicine, 350(20), 2068-2079.
Frommer L, et al. Front Immunol. 2020;11:628. Frommer L, et al. Eur J Endocrinol. 2018;178(5):543-552.
Betterle C, et al. J Clin Endocrinol Metab. 2019;104(2):476-490. Betterle C, et al. J Clin Endocrinol Metab. 2002;87(3):997-1003.Betterle C et al. Autoimmune Polyendocrine Syndromes: Genetic Background and Clinical Features. Front Horm Res, 2019
American Diabetes Association. Diabetes Care. 2023;46(Suppl 1):S140-S157.
Bornstein SR, et al. Lancet. 2016;387(10021):913-924.
Peterson, P., et al. (2008). "Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): A model disease to study molecular aspects of endocrine autoimmunity." Clinical and Experimental Immunology, 135(3), 348-357.
Laakso SM, et al. Regulatory T Cell Deficiency in APECED Is a Functionally Defined Abnormality That Can Be Corrected by IL-2. J Immunol. 2019;203(11):3018-3026. doi: 10.4049/jimmunol.1900432.
Nagamine K, et al. Genomics. 1997;42(1):141-146.
Bottomley MJ, et al. J Biol Chem. 2001;276(44):41357-41364.
Liston A, et al. Immunity. 2003;19(6):903-912.
Finnish-German APECED Consortium. Nat Genet. 1997;17(4):393-398.
Heino M, et al. Hum Mutat. 2000;15(3):293-294.
Orlova EM, et al. Clin Genet. 2010;77(4):370-380 Orlova, E. M., et al. (2020). "Autoimmune polyglandular syndrome type 1: A focus on immune dysregulation." Clinical Immunology, 214, 108385.
Myhre AG, et al. J Clin Endocrinol Metab. 2002;87(3):997-1003.
Ward L, et al. J Pediatr. 1999;134(6):782-784.
Kekäläinen E, et al. J Immunol. 2007;178(10):6031-6037.(2007). *"T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009. H1N1influenza A epitope in narcolepsy."*Nature Immunology, 8(12), 1284–1291. DOI: 10.1038/ni1522
Kisand K, et al. J Exp Med. 2010;207(13):2995-3006. Kisand, K., & Peterson, P. (2020). "Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): A comprehensive review." Journal of Autoimmunity, 110,102443.
Meloni A, et al. J Autoimmun. 2008;31(2):142-148.
PuelA,et al. Science. 2011;332(6025):65-68. Puel A, et al. Science. 2010;332(6025):65-68.
Vojdani A. Front Immunol. 2014;5:166.
Ruiz PJ, et al. J Immunol. 2000;164(6):2990-2995.
Cetani F, et al. Eur J Endocrinol. 2001;144(4):377-381.
Pappas PG, et al. Clin Infect Dis. 2016;62(4):e1-e50.
Lionakis MS, et al. N Engl J Med. 2014;370(18):1760-1771.
Bollerslev J, et al. Eur J Endocrinol. 2015;173(2):G1-G20.
Le V, et al. J Allergy Clin Immunol. 2019;143(6):2278-2281.
Rosenzwajg M, et al. Sci Transl Med. 2019;11(489):eaaw5510.
Tenti S, et al. Autoimmun Rev. 2019;18(5):477-490.
Perheentupa J. J Clin Endocrinol Metab. 2006;91(8):2843-2850.
Rushworth RL, et al. Clin Endocrinol. 2019;90(1):15-22.
Marx A, et al. Nat Rev Cancer. 2015;15(7):424-434.
Rautemaa R, et al. Oral Dis. 2007;13(2):196-205.
Kawasaki E, et al. J Clin Endocrinol Metab. 2016;101(4):1381-1389.
Wenzlau JM, et al. Diabetes. 2007;56(12):3020-3028.
Ueda H, et al. Nature. 2003;423(6939):506-511.
Bottini N, Peterson EJ. Curr Opin Immunol. 2014;31:73-78.
Ziegler AG, et al. Diabetes Care. 2013;36(9):2616-2620.
McLachlan SM, Rapoport B. Endocr Rev. 2014;35(1):59-105.
Long SA, Buckner JH. J Immunol. 2011;186(8):4649-4655.
Gagliani N, et al. Immunity. 2015;43(2):251-263.
Bratland E, et al. J Immunol. 2011;186(2):1209-1216.
Figueroa-Vega N, et al. J Immunol. 2010;184(2):929-935.
Korn T, et al. Annu Rev Immunol. 2009;27:485-517.
Smith TJ, Hegedüs L. Lancet. 2016;388(10047):906-918.
Holt RIG, et al. Diabet Med. 2021;38(5):e14515.
Caio G, et al. Nutrients. 2019;11(10):2375.
Toh BH, et al. Autoimmun Rev. 2017;16(1):75-82.
Bergqvist C, Ezzedine K. Am J Clin Dermatol. 2019;20(1):1-12.
Ospina NS, et al. J Clin Endocrinol Metab. 2016;101(2):364-389.
Jonklaas J, et al. Thyroid. 2014;24(12):1670-1751.
American Diabetes Association. Diabetes Care. 2021;44(Suppl 1):S53-S72.
Miyara M, et al. Immunol Rev. 2011;241(1):132-159.
Erichsen MM, et al. Eur J Endocrinol. 2009;160(2):233-237.
Hoang JK, et al. Radiology. 2013;267(3):672-682.
Ross DS, et al. Thyroid. 2016;26(10):1343-1421.
Orban T, et al. Diabetes Care. 2014;37(4):1069-1075.
Herold KC, et al. N Engl J Med. 2019;381(7):603-613.
Laureti S, et al. J Clin Endocrinol Metab. 1996;81(12):4707-4711.
Fiore E, et al. Thyroid. 2009;19(12):1403-1410.
İmmünolojik Mekanizmalar Laakso, S. M., et al. (2019). "Regulatory T cell defects in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients." Journal of Autoimmunity, 103, 102288.
Anderson, M. S., & Su, M. A. (2016). "AIRE expands: new roles in immune tolerance and beyond." Nature Reviews Immunology, 16(4), 247-258. AIRE geninin immün toleranstaki rolünü ve APS-1 ile ilişkisini açıklayan bir makale.
Bruserud, ., et al. (2018). "AIRE mutations and autoimmune diseases: A systematic review." Journal of Allergy and Clinical Immunology, 141(5), 1594-1603.)
Jerne, N. K. (1974). "Towards a network theory of the immune system." Annals of Immunology, 125C(1-2), 373-389.
Wincent, A., et al. (1999). "Anti-idiotypic antibodies in autoimmune diseases." Immunology Today, 20(5), 234-240.Antiidiotip antikorların otoimmün hastalıklardaki rolünü inceleyen bir çalışma..
Sakaguchi, S. et al. (2008). Cell. (Treg hücrelerinin immün toleranstaki rolü).
Mauri, C. & Bosma, A. (2012). Nat Rev Immunol. (Breg hücreleri ve anti-idiyotipik antikorlar).
Tzioufas et al., 2012 (IVIG'in otoimmün hastalıklardaki rolü)
Smith et al., 2020 (Otoimmün endokrinopatilerde biyolojik tedaviler)
Hober D, Sauter P. Viruses and Autoimmunity. 2010.
Oftedal BE, et al. J Clin Endocrinol Metab. 2015;100(1):E1-E8.
Jeffery LE, et al. J Immunol. 2012;188(5):2127-2135.
Zheng Y, et al. Nat Commun. 2020;11(1):2575.
Gavalas NG, et al. J Clin Endocrinol Metab. 2007;92(6):2105-2110.
Mitchell AL, et al. Diabetes. 2019;68(3):652-662.
Arif S, et al. Diabetologia. 2011;54(7):1778-1789.
Emamaullee JA, et al. Diabetes. 2009;58(1):100-109.
Li D, et al. Cell Death Dis. 2014;5:e1489.
Wang B, et al. J Immunol. 2012;188(1):370-379.
Stylianou C, et al. Cell Death Differ. 2015;22(9):1445-1456.
Pauley KM, et al. J Immunol. 2011;186(4):2392-2401.
Ferré EM, et al. J Clin Invest. 2016;126(4):1513-1528.
Saeki H, et al. J Dermatol. 2019;46(6):476-481.
Toussirot É, et al. Autoimmun Rev. 2020;19(3):102490.
Choi J, et al. Diabetes. 2019;68(4):706-718.
Cutolo M, et al. Autoimmun Rev. 2022;21(3):103013.
Tsokos GC. N Engl J Med. 2011;365(22):2110-2121.
Gilhus NE, et al. Lancet Neurol. 2016;15(10):1023-1036.
Moutsopoulos HM. Lancet. 2014;383(9919):321-332.
Aringer M, et al. Ann Rheum Dis. 2019;78(6):736-745.
Meriggioli MN, Sanders DB. Lancet Neurol. 2009;8(5):475-490. Sanders DB, et al. Neurology. 2016;87(4):419-425.
Bernatsky S, et al. Ann Rheum Dis. 2016;75(4):689-693.
Smolen JS, et al. Lancet. 2016;388(10055):2023-2038.
Lohse AW, et al. J Hepatol. 2015;62(1):S100-S111.
Antonelli A, et al. Endocr Rev. 2020;41(6):891-904.
Eizirik DL, et al. Nat Rev Endocrinol. 2020;16(6):349-362.
Morris DL, et al. Nat Genet. 2016;48(5):510-518.
Gregersen PK, et al. Nat Immunol. 2020;21(7):695-699.
Kariuki SN, Niewold TB. Curr Opin Rheumatol. 2011;23(5):444-448.
Vincent FB, et al. Autoimmun Rev. 2014;13(3):272-279.
Spolski R, Leonard WJ. Nat Rev Immunol. 2014;14(3):154-165.
Ronnblom L, Eloranta ML. Annu Rev Immunol. 2013;31:387-415.
Pender MP, Burrows SR. Nat Rev Neurol. 2014;10(1):15-23.
ACR. Arthritis Care Res. 2019;71(6):717-734.
Kimura A, Kishimoto T. Immunity. 2010;32(4):504-513.
Fanouriakis A, et al. Ann Rheum Dis. 2019;78(6):736-745.
Furie R, et al. Arthritis Rheumatol. 2020;72(2):232-243.
Tandan R, et al. Muscle Nerve. 2017;56(1):148-156.
O'Shea JJ, et al. Annu Rev Med. 2015;66:311-328.
Tektonidou MG, et al. J Am Soc Nephrol. 2017;28(8):2521-2529.
Varga, E., & Farid, N. R. (2009). "The idiotypic network and endocrine autoimmunity: A theoretical framework for Graves' disease and Hashimoto Thyroiditis." Autoimmunity Reviews, *8*(7),592596. https://doi.org/10.1016/j.autrev.2009.02.013 DOI: 10.1016/j.autrev.2009.02.013
Pugliese, A., Yang, M., Kusmarteva, I., Heiple, T., Vendrame, F., Wasserfall, C., & Atkinson, M. A. (2018). "The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: Goals, Operational Model, and Emerging Findings."
Joshi et al. "T cells in patients with narcolepsy target self-antigens of hypocretin neurons" :Nature 2011: 479(7372), s. 216-219 DOI: 10.1038/nature10554
Polanczyk et al "Cutting Edge: Estrogen Drives Expansion of the CD4+CD25+ Regulatory T Cell Compartment" The Journal of Immunology 2004: 173(4),s.2227-2230PMID: 15294932 DOI: 10.4049/jimmunol.173.4.2227
Cocco et,all."Retinal ganglion cell loss in autoimmune optic neuritis: Insights from an experimental model" Journal of Neuroinflammation 2020 17(1), s. 156 PMID: 32 "
Aringer M, Costenbader K, Daikh D, et al. "2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for systemic lupus eritematozus Annals of theRheumatoidDiseases’’2019;78(6):736-745.PMID: 31383717. DOI: 10.1136/annrheumdis-2018-214819
